In spite of a two to fourfold rise in patients with diabetes demanding insulin syringes, we have endeavored to manage the situation and deliver them to end customers, said MPO's Managing Director.
Dr. Saffarieh added that IRCS is taking all necessary measures in order to deliver insulin
syringes to end customers.